Endologix Inc (ELGX) 13.88 $ELGX Endologix Up 61.8%

New Post Public Reply Private Reply Replies (0) Message Board

Aug 1, 2016 at 6:16 PM

Endologix Inc (ELGX) 13.88 $ELGX

Endologix Up 61.8% Since SmarTrend Uptrend Call (ELGX)
Comtex SmarTrend(R) - Thu Jul 28, 12:47PM CDT
SmarTrend identified an Uptrend for Endologix (NASDAQ:ELGX) on March 2nd, 2016 at $8.78. In approximately 5 months, Endologix has returned 61.79% as of today's recent price of $14.21.
ELGX: 13.88 (-0.23)

Upgrade Alert for Endologix (ELGX)
Comtex SmarTrend(R) - Fri Jul 08, 3:01AM CDT
Endologix (NASDAQ:ELGX) was upgraded from Market Perform to Outperform at BMO Capital today. The stock closed yesterday at $13.70 on volume of 2.1 million shares, above average daily volume of 866,000. Over the past year, Endologix has traded in a range of $6.51 to $18.07 and closed yesterday at $13.70, 110% above that low. Over the last five market days, the 200-day moving average (MA) has gone down 0.6% while the 50-day MA has advanced 3.2%.
ELGX: 13.88 (-0.23)

Uptrend Call Working As Endologix Stock Rises 46.1% (ELGX)
Comtex SmarTrend(R) - Wed Jul 06, 12:36AM CDT
SmarTrend identified an Uptrend for Endologix (NASDAQ:ELGX) on March 2nd, 2016 at $8.78. In approximately 4 months, Endologix has returned 46.13% as of today's recent price of $12.83.
ELGX: 13.88 (-0.23)

Endologix Reports Positive Clinical Data on the Nellix EVAS System from a Multicenter Study in Italy
GlobeNewswire - Thu Jun 09, 8:33AM CDT
Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, announced today positive clinical data from the Italian Research Nellix Endoprosthesis ("IRENE"

study at the 2016 Society of Vascular Surgery ("SVS"

Annual Meeting. This retrospective, multicenter study was designed to evaluate the Nellix(R) EndoVascular Aneurysm Sealing System ("Nellix EVAS System"

for the endovascular repair of infrarenal abdominal aortic aneurysms ("AAA"

.
ELGX: 13.88 (-0.23)

Medical Instruments & Supplies Equities Roundup -- Endologix, Becton Dickinson, Waters, and OraSure Technologies
PR Newswire - Thu Jun 09, 7:25AM CDT
On Wednesday, June 08, 2016, the NASDAQ Composite ended the trading session at 4,974.64, up 0.26%; the Dow Jones Industrial Average advanced 0.37% to finish at 18,005.05; and the S&P 500 closed at 2,119.12, up 0.33%. The gains were broad based as all the sectors ended the session in positive. ActiveWallSt.com has initiated coverage on the following equities: Endologix Inc. (NASDAQ: ELGX), Becton, Dickinson and Company (NYSE: BDX), Waters Corporation (NYSE: WAT), and OraSure Technologies Inc. (NASDAQ: OSUR). Learn more about these stocks by accessing their free trade alerts at:
BDX: 176.78 (+0.78), ELGX: 13.88 (-0.23), WAT: 159.58 (+0.65), OSUR: 6.81 (-0.01)

Endologix Up 45.6% Since SmarTrend Uptrend Call (ELGX)
Comtex SmarTrend(R) - Fri Jun 03, 12:48PM CDT
SmarTrend identified an Uptrend for Endologix (NASDAQ:ELGX) on March 2nd, 2016 at $8.78. In approximately 3 months, Endologix has returned 45.56% as of today's recent price of $12.78.
ELGX: 13.88 (-0.23)

Endologix to Present at Jefferies Healthcare Conference
GlobeNewswire - Fri Jun 03, 8:00AM CDT
Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, announced today it will present at the Jefferies Healthcare Conference in New York, NY.
ELGX: 13.88 (-0.23)

Endologix Has Returned 45.0% Since SmarTrend Recommendation (ELGX)
Comtex SmarTrend(R) - Fri May 27, 12:32AM CDT
SmarTrend identified an Uptrend for Endologix (NASDAQ:ELGX) on March 2nd, 2016 at $8.78. In approximately 3 months, Endologix has returned 44.99% as of today's recent price of $12.73.
ELGX: 13.88 (-0.23)

After Yesterday's Rally of 3.49% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Thu May 26, 3:21PM CDT
Endologix (NASDAQ:ELGX) traded in a range yesterday that spanned from a low of $12.33 to a high of $12.93. Yesterday, the shares gained 3.5%, which took the trading range above the 3-day high of $12.59 on volume of 979,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
ELGX: 13.88 (-0.23)

Endologix Reports Positive Clinical Data from the Nellix EVAS FORWARD-IDE Study
GlobeNewswire - Thu May 26, 8:00AM CDT
Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, announced today positive clinical data from the Nellix investigational device exemption (IDE) clinical trial, the EVAS FORWARD-IDE Study (www.clinicaltrials.gov, NCT01726257). This multicenter, prospective, single arm clinical study is designed to evaluate the safety and effectiveness of the Nellix(R) EndoVascular Aneurysm Sealing System ("Nellix EVAS System"

for the endovascular repair of infrarenal abdominal aortic aneurysms ("AAA"

. The data from the EVAS FORWARD-IDE study demonstrated that the Nellix EVAS System met the study primary endpoints for major adverse events at 30 days (safety) and Treatment Success at one year (effectiveness).
ELGX: 13.88 (-0.23)

36.2% Return Seen to Date on SmarTrend Endologix Call (ELGX)
Comtex SmarTrend(R) - Thu May 19, 1:01PM CDT
SmarTrend identified an Uptrend for Endologix (NASDAQ:ELGX) on March 2nd, 2016 at $8.78. In approximately 3 months, Endologix has returned 36.22% as of today's recent price of $11.96.
ELGX: 13.88 (-0.23)

Endologix Completes Patient Enrollment in the Ovation(R) LIFE (Least Invasive Fast-Track EVAR) Study
GlobeNewswire - Mon May 16, 8:00AM CDT
Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, announced today that it has completed patient enrollment in the LIFE study, a multi-center post-market registry designed to evaluate the Ovation Abdominal Stent Graft Platform when used in the treatment of patients with abdominal aortic aneurysms ("AAA"

using a Fast-Track EVAR protocol. The LIFE study is the first of its kind using a Fast-Track EVAR protocol, which includes bi-lateral percutaneous access enabled by the Ovation Platform ultra-low profile (14F) design, avoidance of general anesthesia and intensive care unit ("ICU"

admission post procedure, and next-day discharge.
ELGX: 13.88 (-0.23)

Endologix Reports Results for the First Quarter 2016
GlobeNewswire - Mon May 09, 3:07PM CDT
Endologix, Inc. (NASDAQ:ELGX), developer and marketer of innovative treatments for aortic disorders, today announced financial results for the three months ended March 31, 2016.
ELGX: 13.88 (-0.23)

Shares of ELGX Up 24.3% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Wed May 04, 1:25PM CDT
SmarTrend identified an Uptrend for Endologix (NASDAQ:ELGX) on March 2nd, 2016 at $8.78. In approximately 2 months, Endologix has returned 24.26% as of today's recent price of $10.91.
ELGX: 13.88 (-0.23)

SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Endologix, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors
PR Newswire - Wed May 04, 10:19AM CDT
Purcell Julie & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of fiduciary duty claim involving the board of directors of Endologix, Inc. (NASDAQ:ELGX).
ELGX: 13.88 (-0.23)

Endologix to Participate in Two Investor Conferences in May
GlobeNewswire - Fri Apr 29, 8:00AM CDT
Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, announced today that John McDermott, Chief Executive Officer, and Vaseem Mahboob, Chief Financial Officer, are scheduled to participate at two investor conferences in May. The first conference is the Deutsche Bank 41 Annual Health Care Conference in Boston, Massachusetts.
DB: 13.07 (-0.37), ELGX: 13.88 (-0.23)

Positive Nellix Clinical Data from the ASCEND Study for the Treatment of Juxta and Pararenal AAA Presented at the 38th Annual Charing Cross Symposium
GlobeNewswire - Thu Apr 28, 11:15AM CDT
Endologix, Inc. (Nasdaq:ELGX), developer and marketer of innovative treatments for aortic disorders, announced today the first data presentation from the ASCEND Registry (Aneurysm Study for Complex AAA: Evaluation of Nellix Durability), a physician-initiated registry of the Nellix EndoVascular Aneurysm Sealing System ("Nellix EVAS System"

used with aortic branch stent grafts for the treatment of patients with complex abdominal aortic aneurysms ("AAAs"

. Professor Matthew Thompson, MD, Professor of Vascular Surgery, St. Georges Vascular Institute, London, and one of the principal investigators of the ASCEND Registry, presented the results at the 38th Annual Charing Cross Symposium being held April 26-29 in London, UK. The Nellix EVAS System is approved for investigational use only in the U.S.
ELGX: 13.88 (-0.23)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Power Knot MEA Wins THE BIZZ 2026 for Excellence

Setting the Pace in Waste Management If there's one thing that sticks in my craw, it's how businesses handle food waste. Power Knot Middle East (PKME) seems to have cracked the code by not just leading the charge in organic waste management but also bagging THE BIZZ 2026 award. They’re not just playing industry games; PKME's pulling the strings with real leadership and...

Monteverde's Equity Alert: Scrutinizing Recent M&A Deals

Diving Into M&A Deals Under Monteverde's Lens Wall Street’s not just about suits and skyscrapers; it’s about the nitty-gritty of deals and whether those numbers add up in the investor's favor. So, when Monteverde & Associates PC throws its weight into scrutinizing mergers and acquisitions, you better believe it's worth a second look. See, they’re digging into four...

Black Culture Icon: Plastic-Covered Couch Takes Stage

A Plastic-Laden Piece of History Makes Art Who'd have thought a plastic-covered couch would turn into a cultural artifact? This iconic staple in Black households has done just that, debuting at Brooklyn's CultureCon in a fresh guise. It's more than just an upcycled furniture piece; it's a living archive that encapsulates Black culture, joy, and resilience. The Heart...

ARTBOX Brings Korean Lifestyle Magic to LA Pop-Up

ARTBOX: From Seoul to La-La Land Here's what caught my eye. It's 2026, and Korean lifestyle retailer ARTBOX is making a splash in the U.S.—kicking things off with a pop-up in LA. Now, usually, I'd be skeptical about pop-ups, but you've got to admire the audacity and timing here. They've picked Melrose Avenue, a hotspot for all things trendy, to introduce their mix of...

Monster Energy Dominates Skateboard Podium at SLS Paris

Monster Energy's Skateboard Triumph Hold the front page, because Monster Energy just pulled off a clean sweep in Paris. The company's team riders dominated the Men's Skateboard Street competition at the SLS Paris 2026, with the iconic Nyjah Huston snagging the top spot. It's a story filled with triumph, grit, and a dash of raw talent in a vibrant field of international...

Monteverde Probes Four Key M&A Deals for Fairness

Examining the Intricacies of Pending M&A The merger and acquisition landscape can be vicious, especially when the sharks—those pesky class action lawyers—start circling. And let me tell you, Monteverde & Associates PC is diving headfirst into the fray, launching inquiries into a handful of these deals. This isn't your first stroll down Wall Street if you’ve seen one...

SiBionics and PharmaSens Unveil Diabetes Tech at EASD

Shaking Up Diabetes Care: New Tech Unveiled Imagine a world where managing diabetes isn't a juggling act with multiple devices. That's precisely the future SiBionics and PharmaSens are pitching at the European Association for the Study of Diabetes (EASD) 2026 in Milan. Now, let me tell you, these guys aren't just playing around with ideas; they're aiming to radically...

Unpacking Monteverde's M&A Investigations Hold your horses, folks! The M&A Class Action Firm is stirring the pot with its latest inquiries into some high-profile mergers. We're looking at Lisata Therapeutics, Flag Ship Acquisition Corporation, Baldwin Insurance Group, and ACV Auctions. So what's got Juan Monteverde's legal eagles swooping in on these deals? Well, are we...

Blokees Unveils 90+ New Wonders at Shanghai Fest

A Grand Stage for New Arrivals Picture this: In the bustling and glittering chaos that was the Wonder Festival Shanghai 2026, held from October 3 to 4, Blokees laid down a major marker. More than 500 products, an artillery of imagination and craftsmanship, were on deck across their key lines—Blokees Model Kits and BLOKEES WHEELS. With 90 brand-new creations making their...

Lawsuit Highlights Inaction in School Bus Tragedy

Seeking Justice Amid Heartbreak Tragedy rarely arrives whispered on the wind—more often, it's the train wreck some saw coming long before it hits. The tragic death of Jenna Menias, a 6-year-old from Frankfort, Illinois, falls squarely in this camp. The family's legal lions, Corboy & Demetrio, have slapped two school districts—District 210 and 157-C—with a wrongful...